BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, May 8, 2026
Home » Topics » Diagnostics, BioWorld Science

Diagnostics, BioWorld Science
Diagnostics, BioWorld Science RSS Feed RSS

Clinical results encourage use of [68Ga]DATATOC for imaging neuroendocrine tumors

Nov. 8, 2017

Clinical evaluation of 177Lu-PP-F11N underway in medullary thyroid cancer

Nov. 6, 2017

First-in-human study reported for next-generation PET tau tracer 18F-PI-2620

Nov. 3, 2017

[Ga68]PSMA bimodal probe for radio- and fluorescence-guided surgery of prostate cancer

Oct. 30, 2017

Reversible 18F-labeled tracer GEH200431-B a potential candidate for MAO-B imaging in humans

Oct. 30, 2017

Janssen conducts phase 0 exploratory trial of [18F]MNI-1020 as imaging marker for tau protein

Oct. 30, 2017

Successful tumor imagining with novel somatostatin receptor antagonist 68Ga-NODAGA-LM3

Oct. 30, 2017

Chugai profiles developments of third quarter 2017

Oct. 27, 2017

100% sensitivity of sentinel lymph node detection with [99mTc]Alotech in throat cancer

Oct. 27, 2017

Novel PET tracer 68Ga-NOTA-3PTATE-RGD shows promise for imaging lung cancer, neuroendocrine tumors

Oct. 25, 2017
Previous 1 2 … 43 44 45 46 47 48 49 50 51 … 328 329 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 7, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 5, 2026
  • Rendering of a key measles protein targeted by neutralizing human antibodies

    First measles treatment advances as vaccination rates drop

    BioWorld
    Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
  • The epidermal growth factor receptor in the inactive (left) and active (right) form.

    Cytospire raises £61M series A to target EGFR in solid tumors

    BioWorld
    Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
  • Strategy compass

    Bio Korea 2026: US policy risks shift to execution framework

    BioWorld
    Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing